Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2026

Segment Reporting

Schedule of information about segments

Information about our segments is as follows (in thousands):



		Three Months Ended March 31, 2026									Three Months Ended March 31, 2025
		Life Sciences Services			Life Sciences Products			Total			Life Sciences Services			Life Sciences Products			Total
Revenue from external customers ¹		$	27,435		$	20,363		$	47,798		$	23,213		$	17,827		$	41,040
Intersegment revenue			478			494			972			245			150			395
			27,913			20,857			48,770			23,458			17,977			41,435
Reconciliation of revenue
Elimination of intersegment revenue									(972)									(395)
Total consolidated revenue									47,798									41,040

Less:
Cost of revenue ^1, ²			7,050			9,069						6,660			7,333
Employee related expenses			14,862			5,954						13,051			5,435
Engineering and development expense ³			202			513						983			412
Rent			1,851			178						1,803			187
Other segment items ⁴			4,044			1,476						3,445			1,100
Adjusted EBITDA for reportable segments		$	(96)		$	3,667		$	3,571		$	(2,484)		$	3,510		$	1,026

Corporate overhead costs									(4,182)									(3,845)
Depreciation and amortization expense									(6,402)									(6,134)
Acquisition and integration costs									-									(1)
Cost reduction initiatives									-									(216)
Investment income									3,090									1,573
Unrealized loss on investments									(2,105)									(193)
Foreign currency loss									(454)									(245)
Interest expense, net									(432)									(583)
Stock-based compensation expense									(2,395)									(3,064)
Change in fair value of contingent consideration									(15)									5,178
Income taxes									(108)									(234)
Loss from continuing operations								$	(9,432)								$	(6,738)

(1) Life Sciences Services segment includes immaterial revenue from external customers and cost of revenue associated with Life Sciences Products revenue and Life Sciences Products cost of products revenue, respectively.

(2) Cost of revenue is exclusive of employee related expenses of $7.5 million and $6.9 million, depreciation and amortization of $2.2 million and $2.0 million, stock-based compensation of $0.4 million and $0.6 million, and rent of $0.6 million and $0.8 million for the three months ended March 31, 2026 and 2025, respectively.

(3) Engineering and development expense is exclusive of employee related expenses of $2.9 million and $2.3 million, stock-based compensation of $0.2 million and $0.2 million, and depreciation and amortization of $0.1 million and $0.1 million for the three months ended March 31, 2026 and 2025, respectively.

(4) Other segment items primarily includes professional services, facility allocations, dues and subscriptions, audit fees, insurance, legal fees, and travel expense.